According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...

Inflammatory bowel diseases (IBDs), which include ulcerative colitis (UC) and Crohn’s disease (CD), are chronic conditions ...

This study provides a valuable new resource to investigate the molecular basis of the particular features characterizing the pipefish embryo. The authors found both unique and shared gene expression ...

In this study, we successfully developed an allogeneic anti-CD70 CAR-T cell therapy using a triple gene knockout (tKO) strategy combined with the expression of a self-activated and protective (SAP) ...

As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in tandem thanks to advancements in technology and a growing body of research on ...

It seems complicated enough to reach the market with a cell or gene therapy, but the struggle isn’t over at that point. The EMA can still withdraw a marketing application due to safety issues or if ...

Eating foods high in key nutrients, including iron, folic acid, and vitamin B12, and limiting alcohol may help increase your red blood cell count ... that this won’t guarantee a higher RBC ...

The TP53 gene is a gene that is mutated in many cancers. It is the most common gene mutation found in cancer cells. A tumor-suppressor gene, TP53 codes for a protein that inhibits the development and ...

That was a weird thing to be happening in cell biology. But at first it seemed to many researchers little more than a quirk and didn’t excite much ... information from a gene to the machinery ...

After processing a small sample of saliva, the device sends results wirelessly to a user's cell phone ... while the testing module is reusable. In addition to Ebrahimi and Asgharian, the co ...

In a significant step forward for India’s cancer treatment, Immuneel Therapeutics, a leading cell and gene therapy statrtup backed by entrepreneur Kiran Mazumdar-Shaw, has unveiled Qartemi, the ...